Literature DB >> 16317121

Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women.

Thomas Clavel1, Matteo Fallani, Patricia Lepage, Florence Levenez, Jacinthe Mathey, Violaine Rochet, Michèle Sérézat, Malène Sutren, Gemma Henderson, Catherine Bennetau-Pelissero, Françoise Tondu, Michael Blaut, Joël Doré, Véronique Coxam.   

Abstract

Dietary phytoestrogens, such as isoflavones, are used as food additives to prevent menopause-related disorders. In addition to other factors, their bioavailability strongly depends on the activity of intestinal bacteria but the underlying interactions remain poorly understood. A randomized, double-blind, placebo-controlled study was undertaken with 39 postmenopausal women to characterize changes in the dominant microbial communities of the intestinal tract after 2 mo of isoflavone supplementation with and without pro- or prebiotic. The diversity and composition of the dominant microbiota were analyzed by temporal temperature-gradient gel electrophoresis (TTGE) and fluorescent in situ hybridization. Isoflavones alone stimulated dominant microorganisms of the Clostridium coccoides-Eubacterium rectale cluster, Lactobacillus-Enterococcus group, Faecalibacterium prausnitzii subgroup, and Bifidobacterium genus. The stimulation of the Clostridium coccoides-Eubacterium rectale cluster depended on the women's equol excretion and was transient, with the exception of a prolonged bifidogenic effect. Lasting changes in the diversity of the dominant species were also observed. The probiotic strain supplied could be detected by TTGE during its passage through the intestinal tract, and ingestion of fructooligosaccharides triggered a marked and specific bifidogenic effect. In conclusion, this is the first human study that shows changes in the diversity and composition of dominant bacterial communities in response to dietary supplementation with hormone-related compounds combined with functional foods.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16317121     DOI: 10.1093/jn/135.12.2786

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  30 in total

1.  Reduction of inflammation in chronic pancreatitis using a soy bread intervention: A feasibility study.

Authors:  Jennifer Ahn-Jarvis; Erin Lombardo; Zobeida Cruz-Monserrate; Niharika Badi; Olivia Crowe; Sabrina Kaul; Hannah Komar; Somashekar G Krishna; Gregory B Lesinski; Thomas A Mace; Mitchell L Ramsey; Kristen Roberts; Kyle Stinehart; Madelyn Traczek; Darwin L Conwell; Yael Vodovotz; Phil A Hart
Journal:  Pancreatology       Date:  2020-06-06       Impact factor: 3.996

2.  Metabolic fate of polyphenols in the human superorganism.

Authors:  John van Duynhoven; Elaine E Vaughan; Doris M Jacobs; Robèr A Kemperman; Ewoud J J van Velzen; Gabriele Gross; Laure C Roger; Sam Possemiers; Age K Smilde; Joël Doré; Johan A Westerhuis; Tom Van de Wiele
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-25       Impact factor: 11.205

3.  Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii.

Authors:  Sylvie Miquel; Rebeca Martín; Chantal Bridonneau; Véronique Robert; Harry Sokol; Luis G Bermúdez-Humarán; Muriel Thomas; Philippe Langella
Journal:  Gut Microbes       Date:  2014-01-22

4.  ERβ and Inflammation.

Authors:  Linnea Hases; Amena Archer; Cecilia Williams
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine.

Authors:  Anastasia Matthies; Thomas Clavel; Michael Gütschow; Wolfram Engst; Dirk Haller; Michael Blaut; Annett Braune
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

Review 6.  Gut microbiome in neuroendocrine and neuroimmune interactions: The case of genistein.

Authors:  Tai L Guo; Yingjia Chen; Hannah Shibo Xu; Callie M McDonough; Guannan Huang
Journal:  Toxicol Appl Pharmacol       Date:  2020-07-14       Impact factor: 4.219

7.  Isoflavone Intake and the Risk of Coronary Heart Disease in US Men and Women: Results From 3 Prospective Cohort Studies.

Authors:  Le Ma; Gang Liu; Ming Ding; Geng Zong; Frank B Hu; Walter C Willett; Eric B Rimm; JoAnn E Manson; Qi Sun
Journal:  Circulation       Date:  2020-03-23       Impact factor: 29.690

8.  High-fat diet alters gut microbiota physiology in mice.

Authors:  Hannelore Daniel; Amin Moghaddas Gholami; David Berry; Charles Desmarchelier; Hannes Hahne; Gunnar Loh; Stanislas Mondot; Patricia Lepage; Michael Rothballer; Alesia Walker; Christoph Böhm; Mareike Wenning; Michael Wagner; Michael Blaut; Philippe Schmitt-Kopplin; Bernhard Kuster; Dirk Haller; Thomas Clavel
Journal:  ISME J       Date:  2013-09-12       Impact factor: 10.302

9.  Application of sequence-dependent electrophoresis fingerprinting in exploring biodiversity and population dynamics of human intestinal microbiota: what can be revealed?

Authors:  Geert Huys; Tom Vanhoutte; Peter Vandamme
Journal:  Interdiscip Perspect Infect Dis       Date:  2008-12-14

10.  Isoflavone metabolism and bone-sparing effects of daidzein-metabolites.

Authors:  Mariko Uehara
Journal:  J Clin Biochem Nutr       Date:  2013-05-01       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.